NCT05878782

Brief Summary

The purpose of this randomized controlled superiority trial is to evaluate the impact of occupational therapy assessment and intervention on the quality of life of elderly cancer patients. Patients will be randomized into 3 parallel, multicenter arms with patient-reported outcome and blinded evaluator.

  • Experimental group A will combine the assessment of occupational problems (MCRO) and an occupational therapy intervention.
  • Experimental group B will have only the MCRO assessment because the occupational problems assessment alone (without intervention) could improve quality of life and occupational performance outcomes, according to the Nielsen, 2019 study
  • Group C will have the usual cancer management care combining specific treatments and supportive care.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
232

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 26, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2026

Completed
Last Updated

May 26, 2023

Status Verified

May 1, 2023

Enrollment Period

2.7 years

First QC Date

May 19, 2023

Last Update Submit

May 19, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quality of life (QLQ-C30 questionnaire)

    Evolution of the EORTC QLQ-C30 role functioning score at 3 months

    3 months

Study Arms (3)

Occupational therapy intervention associated with MCRO assesment.

EXPERIMENTAL

the experimental care of this group will combine the assessment of occupational problems (MCRO) and an occupational therapy intervention.

Other: MCRO+Occupational therapy

MCRO assessment without intervention

EXPERIMENTAL

This experimental group will have only the MCRO assessment because the occupational problems assessment alone (without intervention) could improve quality of life and occupational performance outcomes, according to the Nielsen, 2019 study

Other: MCRO without intervention

Usual care

NO INTERVENTION

this group will have the usual cancer management care combining specific treatments and supportive care.

Interventions

Experimental group A will combine the assessment of occupational problems (MCRO) and an occupational therapy intervention.

Also known as: experimental arm A :Occupational therapy intervention associated with MCRO assesment
Occupational therapy intervention associated with MCRO assesment.

Experimental group B will have only the MCRO assessment because the occupational problems assessment alone (without intervention) could improve quality of life and occupational performance outcomes, according to the Nielsen, 2019 study

Also known as: experimental arm B: MCRO assessment only
MCRO assessment without intervention

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • ≥ 70 years;
  • Colorectal, breast, prostate or lung cancer;
  • Between 1 and 3 months after the start of cancer treatment depending on the type of treatment (Surgery and/or systemic treatment and/or radiotherapy);
  • For curative purposes;
  • Affiliated to a social security scheme;
  • Living at home;
  • Agreeing to participate in the research and having given a free, informed and signed consent

You may not qualify if:

  • person caring for a patient meeting the above criteria;
  • Living with the patient;
  • Agreeing to participate in the research and having given free, informed and signed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Engels C, Marliac Schweitzer S, Blond O, Boulahssass R, David C, Faure H, Gaborit C, Kirscher S, Doyle Lyons K, Machado Antunes L, Morisset L, Pergolotti M, Pierro M, Pineau-Ribas C, Thamie S, Rollot-Trad F, Canoui-Poitrine F. Effects of occupational therapy on quality of life, occupational performance, and occupational satisfaction in older adults with cancer: a multicentre, pragmatic, randomized, controlled trial protocol (OCEAN-OT). BMC Geriatr. 2025 Nov 27;25(1):1064. doi: 10.1186/s12877-025-06535-y.

MeSH Terms

Conditions

Neoplasms

Interventions

Methods

Intervention Hierarchy (Ancestors)

Investigative Techniques

Central Study Contacts

Cynthia Engels, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: A randomized, controlled, superiority trial in 3 parallel arms
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2023

First Posted

May 26, 2023

Study Start

September 1, 2023

Primary Completion

May 1, 2026

Study Completion

May 1, 2026

Last Updated

May 26, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share